Robotic surgery for locally advanced non-small cell lung cancer
نویسندگان
چکیده
منابع مشابه
Multimodality treatment in locally advanced non-small cell lung cancer.
Prognosis in patients with locally advanced non-small cell lung cancer (NSCLC) is poor (five year survival rate of 5% [1]). Radiotherapy (RT), chemotherapy (CT) and surgery (S), as single modality therapeutical approaches are unable to eradicate locoregional disease and to control systemic microscopic disease. Concurrent chemoradiation (CTRT) is at present time deemed to be the standard of care...
متن کاملNeoadjuvant chemotherapy in locally advanced non-small cell lung cancer.
OBJECTIVE The objective of this study was to evaluate the role of neoadjuvant chemotherapy in the treatment of locally advanced non small cell lung cancer (NSCLC) followed by radiotherapy versus radiotherapy alone. MATERIAL AND METHODS Sixty nine patients were randomized to chemotherapy (group A) or radiotherapy alone (group B). The induction chemotherapy consists of cisplatin (80 mg/m2) day ...
متن کاملInduction chemoradiotherapy followed by surgery for locally advanced non-small cell lung cancer.
We examined the efficacy and toxicity of a divided schedule of cisplatin and vinorelbine with concurrent radiotherapy followed by surgery in patients with locally advanced non-small cell lung cancer (NSCLC). Patients with clinical stage IIIA or IIIB NSCLC were eligible if they had a performance status of 0 or 1, were 75 years or younger, and had adequate organ function. Patients were treated wi...
متن کاملSurgery for non-small cell lung cancer.
BACKGROUND As part of an evaluation of the lung cancer surgery at Akershus University hospital we wanted to describe the lung cancer surgery programme, assess 30-day mortality and review complications. MATERIAL AND METHOD We retrospectively examined medical records of all patients undergoing potentially curative surgery for non-small-cell lung cancer. RESULTS The 99 patients operated on wer...
متن کامل2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer.
To complement the existing treatment guidelines for all tumour types, ESMO organises consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO Consensus Conference on Lung Cancer was held on 11-12 May 2013 in Lugano. A total of 35 experts met to address several questions on non-small-cell lung cancer (NSCLC) in each of four areas: pathology and molecular biomarkers,...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Visualized Surgery
سال: 2021
ISSN: 2221-2965
DOI: 10.21037/jovs-20-114